News Article

Applied Nanotech Receives $400K Contract from California Citrus Research Board: Funds to be used for early detection of HLB Disease
Date: Nov 12, 2013
Source: Company Data ( click here to go to the source)

Featured firm in this article: Applied Nanotech Inc of Austin, TX

Austin, Texas - November 12, 2013 - Applied Nanotech Holdings, Inc. (OTC QB: APNT) announced that it has received a contract from the California Citrus Research Board (CRB), worth approximately $400,000, that will fund increased instrument development and testing for HLB disease and other pathogens in citrus trees, with a focus on early detection.

The contract is a Year 2 continuation of the development and refinement of Point of Analysis Agricultural Pathogen detection systems. This contract includes further development of the EZKnowz™ pathogen detection systems for faster response and research to expand the instrument capability to other citrus pathogens. This novel point of analysis agriculture pathology system will be used to boost research and understanding into detection and monitoring of citrus diseases.

HLB (Huanglongbing, also known as Citrus Greening Disease) is a bacterial infection that poses a severe threat to citrus production worldwide. The citrus industry of Florida has been significantly impacted. Early detection of the disease is essential since the disease spreads from tree to tree and significantly impacts fruit quality and tree death. Removal of infected trees is the most effective method to contain and eradicate the disease.

Greening disease (HLB) and other pathogens cause more than $1 billion in lost revenue to citrus growers annually. Early detection and monitoring will not only save billions of dollars, but also millions of trees while keeping fruit and juice prices from skyrocketing.

"The advancement of this technology fills a critical need for the continued production of citrus worldwide," reported Ken Keck, President of the Citrus Research Board. "I have already witnessed how damaging this disease has been to the citrus industry in Florida; the CRB is doing everything it can to prevent the spread of HLB into California."

APNT will be partnering with UC Davis, one of the world's premiere research institutions with a long and distinguished track record in addressing the needs of the citrus industry. Professor Cristina E. Davis and her team have expertise in mobile chem/bio sensor platforms and accurate identification algorithms, developed over several years of experience working with the citrus industry as well as topics critical to human health and safety.

"This system and technology will provide an important asset to the citrus industry's early disease detection and monitoring needs in preventing the spread of industry-crippling diseases," said Dr. Zvi Yaniv, President and Chief Operating Officer of APNT. "This contract extension is important to accelerating commercial development of our technology and is a very important milestone towards convincing the healthcare industry that breath analysis using our EZKnowz™ broad chemical, point-of-care sensor platform could revolutionize and lower the cost of digital preventive healthcare."

Applied Nanotech Holdings, Inc. (APNT) is an Austin, Texas-based global leader in nanotechnology research and development and has ongoing research programs and license agreements with product innovators around the world. For information about Applied Nanotech Holdings, Inc., please visit

About Citrus Research Board
The Citrus Research Board is a grower-funded program to sponsor and direct research for the betterment of citrus production in California. The program includes work on new varieties, quality assurance, disease prevention, and pest management systems. The CRB also cooperates with the Florida Citrus Research and Development Foundation to address issues of national and international concern. HLB is considered to be the highest threat to all citrus production regions worldwide. More information can be found at the CRB Website:

About UC Davis
For more than 100 years, UC Davis has engaged in teaching, research and public service that matter to California and transform the world. Located close to the state capital, UC Davis has more than 33,000 students, 2,500 faculty. 21,000 staff, an annual research budget of nearly $750 million, a comprehensive health system, and 13 specialized research centers. The university offers interdisciplinary graduate study and over 100 undergraduate majors in four colleges — Agricultural and Environmental Sciences, Biological Sciences, Engineering, and Letters and Science. It also houses six professional schools — Education, Law, Management, Medicine, Veterinary Medicine and the Betty Irene Moore School of Nursing.

Safe Harbor Statement
This press release contains forward-looking statements that involve risks and uncertainties concerning our business, products, and financial results. Actual results may differ materially from the results predicted. More information about potential risk factors that could affect our business, products, and financial results are included in our annual report on Form 10-K for the fiscal year ended December 31, 2012, and in reports subsequently filed by us with the Securities and Exchange Commission ("SEC"). All documents are available through the SEC's Electronic Data Gathering Analysis and Retrieval System (EDGAR) at or from our website listed above. We hereby disclaim any obligation to publicly update the information provided above, including forward-looking statements, to reflect subsequent events or circumstances

Company Contact:
Applied Nanotech Holdings, Inc.